- [Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
[Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
Deutsche medizinische Wochenschrift (1946) (2014-05-08)
G J Molderings, J Homann, S Brettner, M Raithel, T Frieling
PMID24801454
ABSTRACT
In the present paper clinical phenotypes, pathogenetic relationships, and diagnostic algorithms as well as therapeutic concepts of/for systemic mast cell activation disease are reviewed. The reader should be able to recognize and diagnose a systemic mast cell activation disease, as well as to counsel a personalized drug therapy. In the case of chronic multisystem polymorbidity systemic mast cell activation disease should be considered as a differential diagnosis at an early stage. In most cases, specific, little invasive investigations allow diagnosing the disease and, hence, an appropriate therapy can be initiated.
MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto
Sigma-Aldrich
Acido L-ascorbico, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Acido L-ascorbico, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Supelco
(+)- L-ascorbato di sodio, Pharmaceutical Secondary Standard; Certified Reference Material
Acido L-ascorbico, European Pharmacopoeia (EP) Reference Standard
Supelco
Acido L-ascorbico, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
(+)- L-ascorbato di sodio, European Pharmacopoeia (EP) Reference Standard
Supelco
Ranitidine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Ketotifen hydrogen fumarate, European Pharmacopoeia (EP) Reference Standard
Ketotifen for peak identification, European Pharmacopoeia (EP) Reference Standard
Ranitidine hydrochloride, European Pharmacopoeia (EP) Reference Standard